Editorial

1. Preface

Review

1. Rethinking bioequivalence and equivalence requirements of orally inhaled drug products
2. Inhaled nicotine replacement therapy
3. Inhalation of nanoparticle-based drug for lung cancer treatment:Advantages and challenges
4. Practical,regulatory and clinical considerations for development of inhalation drug products

Original Research Paper

1. Mathematical approach for understandingdeagglomeration behaviour of drug powder in formulations with coarse carrier
2. The effects of surface morphology on the aerosol performance of spray-dried particles within HFA 134a based metered dose formulations
3. Delivery of theophylline as dry powder for inhalation
4. Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery
5. The in fl uence of amino acids on aztreonam spray-dried powders for inhalation
6. Novel potential for optimization of antitubercular therapy:Pulmonary delivery of rifampicin lipospheres
7. GUIDE FOR AUTHORS